$TCBI

Scurlock John Matthew purchased $4K of TCBI

Scurlock John Matthew (Chief Financial Officer) purchased 44 shares of TEXAS CAPITAL BANCSHARES INC/TX (TCBI) at $101.29 on 2026-06-15.

Original reporting
SEC EDGAR · Scurlock John Matthew
Published Jun 16, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 16, 2026, 8:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TCBI
Bullish
high confidence
Mentioned
$TCBI
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TCBIBullishLow
01

Why it matters

The disclosure adds incremental sentiment/positioning information but does not change the company’s financial outlook or introduce new business developments.

02

Market read

Traders may note the insider buy as a minor positive, but it is unlikely to drive material repricing without accompanying company catalysts.

03

What to watch

The disclosed buy is small in dollar terms and lacks a 10b5-1 plan, so it may not reflect a systematic conviction signal.

Relevance 4/10Novelty 6/10Timing: Filed 2026-06-16; transaction dated 2026-06-15.

Background

The filing is an SEC Form 4 insider transaction for Texas Capital Bancshares, reported by the CFO.

Company-level read

Ticker impact

$TCBIBullishHigh confidence
Context

Texas Capital Bancshares CFO John Matthew Scurlock bought 44 shares on 2026-06-15 at $101.2869/share via an open-market purchase.

Expected impact

Limited near-term impact; any effect is likely small and short-lived unless followed by additional insider buying or company-specific news.

Evidence & confidence

This is a Form 4 insider transaction with small share count and no 10b5-1 plan; it provides sentiment/positioning information rather than new operating or financial guidance.

Market effects

No sector-level read-through; this is company-specific insider activity.

None indicated beyond local sentiment for the issuer.

None; single-insider Form 4 disclosure.

Counterpoint

Insider buys can be driven by diversification, liquidity needs, or routine compensation-related behavior rather than a bullish view on fundamentals.

Key entities

  • Texas Capital Bancshares Inc

    Issuer of the insider transaction disclosed on SEC Form 4.

  • John Matthew Scurlock

    Chief Financial Officer who reported an open-market purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TCBIMed

DA Davidson cuts Texas Capital Bancshares stock price target on expense outlook

DA Davidson reduced Texas Capital Bancshares (TCBI) price target to $105 from $106, citing higher expected expenses. The bank reported strong Q3 2026 results, with EPS of $2.35 and revenue of $356.6M, beating estimates. Revenue grew 35.6% YoY, driven by net interest margin expansion and record investment banking. Management plans aggressive hiring, which may increase costs. Credit trends were mixed, with pressure on mortgage finance.

$TCBIMed

Texas Capital Bancshares Inc (TCBI) (Q3 2026) Earnings Call Highlights: Record EPS, Revenue

Texas Capital Bancshares (TCBI) reported Q3 2026 earnings with record adjusted EPS of $2.35 (up 8% YoY) and adjusted total revenue of $357M (up 5% YoY). Non-interest income rose 19% YoY to $82M. Commercial loans grew 13% YoY to $13.4B. Net interest margin was 3.44%, slightly below last year's 3.47%. Mortgage finance loans declined 15% linked quarter. The company authorized a new $200M share repurchase program.

$TCBIMed

Texas Capital Bancshares Q3 Earnings Call Highlights

Texas Capital Bancshares (TCBI) reported Q3 net interest income of $275M, up $3.2M YoY, with a net interest margin of 3.44%. Commercial loans grew 13% YoY to $13.4B, while CRE and mortgage finance loans declined. Expenses fell 2% QoQ to $199.6M. The company expects stable net interest income and margin in Q4. It repurchased 1.05M shares and approved a new $200M buyback program. Full-year 2026 revenue growth is forecasted in the high single digits.